• Episode: 64 - Peyton Greenside on AI’s Role in Antibody Engineering, Optimization, and More

  • 2024/08/13
  • 再生時間： 33 分
  • ポッドキャスト

Episode: 64 - Peyton Greenside on AI’s Role in Antibody Engineering, Optimization, and More

無料で聴く

ポッドキャストの詳細を見る

  • サマリー

  • In this episode of The Chain, host Nimish Gera, Ph.D., vice president of biologics at Mythic Therapeutics, speaks with Peyton Greenside, CSO and co-founder of BigHat Biosciences, about the role of AI and machine learning in antibody engineering and targeting complex modalities, including bispecifics and ADCs. Greenside also discusses the work her organization does, what BigHat is doing to ensure the quality of data to train their AI models with, the methods of approaching harder targets such as GPCRs, and certain properties that AI can optimize better.

    続きを読む 一部表示

あらすじ・解説

In this episode of The Chain, host Nimish Gera, Ph.D., vice president of biologics at Mythic Therapeutics, speaks with Peyton Greenside, CSO and co-founder of BigHat Biosciences, about the role of AI and machine learning in antibody engineering and targeting complex modalities, including bispecifics and ADCs. Greenside also discusses the work her organization does, what BigHat is doing to ensure the quality of data to train their AI models with, the methods of approaching harder targets such as GPCRs, and certain properties that AI can optimize better.

続きを読む 一部表示

Episode: 64 - Peyton Greenside on AI’s Role in Antibody Engineering, Optimization, and Moreに寄せられたリスナーの声

カスタマーレビュー：以下のタブを選択することで、他のサイトのレビューをご覧になれます。

Audible.co.jp

Amazon.co.jp
レビューはまだありません。